KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Accounts Payables (2016 - 2025)

Pfizer (PFE) has disclosed Accounts Payables for 17 consecutive years, with $5.2 billion as the latest value for Q4 2025.

  • Quarterly Accounts Payables fell 6.98% to $5.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.2 billion through Dec 2025, down 6.98% year-over-year, with the annual reading at $5.2 billion for FY2025, 6.98% down from the prior year.
  • Accounts Payables for Q4 2025 was $5.2 billion at Pfizer, up from $5.0 billion in the prior quarter.
  • The five-year high for Accounts Payables was $6.8 billion in Q4 2022, with the low at $4.1 billion in Q2 2021.
  • Average Accounts Payables over 5 years is $5.5 billion, with a median of $5.4 billion recorded in 2022.
  • The sharpest move saw Accounts Payables soared 43.47% in 2022, then fell 16.05% in 2024.
  • Over 5 years, Accounts Payables stood at $5.6 billion in 2021, then rose by 22.07% to $6.8 billion in 2022, then decreased by 1.45% to $6.7 billion in 2023, then dropped by 16.05% to $5.6 billion in 2024, then decreased by 6.98% to $5.2 billion in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $5.2 billion, $5.0 billion, and $5.2 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.